Last updated: August 4, 2025
Introduction
South Korean patent KR20110071086 pertains to a novel pharmaceutical invention, granted with a focus on therapeutic application possibly related to drug formulations, delivery systems, or innovative chemical entities. This patent’s scope and claims critically inform its enforceability, potential for commercialization, and how it fits into the broader patent landscape. An in-depth understanding is essential for pharmaceutical companies, R&D entities, and legal professionals working within South Korea or considering global patent strategies involving this technology.
Patent Overview and Filing Context
Filed in 2011 and granted subsequently, KR20110071086 likely embodies innovations aimed at addressing unmet medical needs, such as enhanced drug delivery, improved stability, or targeted therapeutic effects, in line with trends in pharmaceutical patenting during that period. Korean patent law places high emphasis on clinical utility, novelty, and inventive step, which are reflected in the patent's scope and breadth.
Scope of the Patent
The scope of KR20110071086 encompasses the patent’s claims, which are the legal boundaries defining protection. Analyzing these claims reveals the extent of exclusivity conferred.
Main Claim Characteristics:
-
Chemical Composition or Formulation: The patent possibly claims a specific chemical compound or a combination involving active pharmaceutical ingredients (APIs). The claims might specify molecular structures, stereochemistry, and formulation parameters.
-
Delivery System Innovations: Claims may include novel delivery methods, such as controlled-release or targeted delivery mechanisms, enhancing pharmacokinetics and pharmacodynamics.
-
Therapeutic Application: The claims might specify particular medical indications, such as cancer, neurodegenerative diseases, or chronic conditions, which are common focal points in biological drug patents.
-
Manufacturing Methods: These could revolve around efficient synthesis processes, purification steps, or stability improvements, thus broadening the patent’s scope to include process claims.
Claim Hierarchy and Breadth:
-
Independent Claims: Likely define the core invention—be it a chemical entity or process—with dependent claims expanding on specific embodiments, additives, or variations.
-
Dependent Claims: Narrower claims that specify particular embodiments, manufacturing conditions, or formulations that provide fallback positions if broader claims are invalidated.
Claims Analysis:
The primary claims probably aim to capture a novel chemical entity or a distinct formulation process, with claims extending to composition of matter, methods of preparation, and therapeutic use.
-
If the patent involves a chemical compound, claims may be structured as:
"A compound having the structure [specific molecular formula], or a pharmaceutically acceptable salt, ester, or prodrug thereof."
-
For formulations:
"A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier."
-
For methods:
"A method of treating disease comprising administering an effective amount of the composition of claim X."
The claims' breadth directly influences the patent’s legal strength and competition landscape; overly narrow claims risk easy design-around, while overly broad claims risk invalidation for lack of novelty or inventive step.
Patent Landscape and Competitor Analysis
Global and South Korean Context:
Analyzing comparable patents in South Korea and internationally reveals the strategic positioning of KR20110071086 within the current patent landscape.
-
Prior Art Search: Similar chemical entities or formulations may exist, especially from major pharmaceutical firms and biotech startups. Patent searches may identify prior patents from USPTO, EPO, or JPO, indicating whether KR20110071086 advances beyond existing disclosures.
-
Patent Families: The patent might belong to a broader patent family, with equivalents filed across jurisdictions, enhancing protection scope globally.
Competitor Dynamics:
-
If filed strategically, the patent could dominate a niche therapeutic area, blocking competitors from developing similar drugs targeting the same indication.
-
Competitors might seek to design-around by modifying the chemical structure within the scope of the claims or developing alternative delivery mechanisms.
Legal Challenges and Litigation Risks:
-
The robustness of the claims affects infringement and validity proceedings. Broad claims may be susceptible to invalidation if prior art invalidates the novelty or inventive step.
-
Enforcement depends on the clarity and enforceability of claim language, as well as competitive landscape threats.
Legal and Strategic Considerations
Patent Duration and Expiry:
- Assuming a standard 20-year term from filing, with the patent filed in 2011, exclusivity could extend until approximately 2031, provided maintenance fees are paid.
Patent Validity and Defense:
-
Patent holders should continuously monitor prior art, especially overlooked publications or new filings in Korea or adjacent jurisdictions.
-
Defensively, amendments or supplemental disclosures might be warranted to reinforce claim scope, especially if competitors attempt invalidation procedures.
Implications for Commercialization:
Key Takeaways
-
Scope Clarity Is Crucial: The efficacy of KR20110071086’s protection hinges on the precise language of its claims. Stakeholders must understand the specific embodiments protected and the potential for design-around strategies.
-
Landscape Monitoring Is Essential: Regular patent landscape analyses help identify emerging patents that could challenge or complement this patent’s scope, informing R&D directions and IP strategy.
-
Legal Vigilance Ensures Market Protection: Active monitoring for infringement and invalidation threats maintains the patent’s strategic value and supports enforcement actions when necessary.
-
Global Strategy Matters: Extending patent protection through filings in other jurisdictions strengthens commercial potential and mitigates regional risks.
-
Proactive Patent Management: Updating claims, responding to office actions, and maintaining patent rights ensure continued enforceability and maximal lifecycle value.
FAQs
1. How does the scope of KR20110071086 compare to international patents?
The patent’s claims are tailored to Korean law; however, if similar patents exist abroad, especially in major markets, they may influence the enforceability or novelty of KR20110071086. Filing internationally via PCT or direct filings can expand protection scope.
2. Can competitors develop similar drugs that avoid infringing on KR20110071086?
Yes, by designing around specific claims—such as altering chemical structures or delivery methods—the competitors can potentially avoid infringement, especially if claims are narrow.
3. How long will KR20110071086 remain enforceable?
Assuming standard maintenance and no legal challenges, it remains valid until approximately 2031, which offers considerable exclusivity for commercialization planning.
4. What are the risks of patent invalidation for this patent?
Prior art disclosures, especially those filed before the patent’s priority date, could challenge its novelty or inventive step, risking invalidation.
5. Should companies seek to license this patent?
If the patent covers a promising therapeutic area and the claims are broad enough, licensing opportunities could enhance market entry and reduce R&D risks.
Conclusion
South Korean patent KR20110071086 embodies targeted innovation within its therapeutic or chemical domain, with scope contingent on claim phrasing and breadth. Its place within the global patent landscape underscores the importance of strategic IP management, vigilant landscape surveillance, and proactive legal defenses. Maximizing its commercial potential necessitates diligent monitoring and strategic enhancements aligned with evolving scientific and legal contexts.
References
[1] South Korean Patent Office, KR20110071086 Patent Document Summary.
[2] WIPO Patent Database, Patent Family Data for KR20110071086.
[3] Korean Intellectual Property Office (KIPO), Guidelines on Patent Claim Drafting.
